Press release
Zonisamide Market available in the latest report forecast by 2029
Zonisamide Market
Report Scope and Methodology:
Report Scope: The comprehensive research report explores the Zonisamide Market, its drivers, restraints, and regional insights. It offers a detailed analysis of market dynamics, trends, and growth opportunities in the industry. The report covers segments such as strength (25 mg, 50 mg, and 100 mg) and application (adult, pediatric, and geriatric).
Research Methodology: The report is based on extensive research, incorporating data from 2022 as a base year, real numbers, outputs from key players, and global market leaders. It considers the impact of the COVID-19 pandemic and analyzes trends over the past five years while projecting market trends through 2029.
For detail insights on this market, request for methodology here @
https://www.maximizemarketresearch.com/market-report/zonisamide-market/148295/
What are Zonisamide Market Dynamics?
Drivers:
Rising Epilepsy Cases: Epilepsy affects around 50 million people worldwide, making it one of the most common neurological disorders. With approximately 2.4 million new cases diagnosed each year, the increase in epilepsy cases drives the demand for Zonisamide.
Second-Generation Antiepileptic Drugs: Second-generation antiepileptic drugs, including Zonisamide, offer benefits such as reduced drug interactions and side effects, driving their adoption.
Growing Geriatric Population: The elderly population is increasingly affected by epilepsy due to factors such as stroke and brain tumors. With a rising geriatric population, the demand for Zonisamide is expected to increase.
Restraints:
Drug Supply Shortages: A sharp increase in drug supply shortages poses a significant challenge to the Zonisamide market. Patients stockpile medicines due to shortages, leading to concerns about the global medicine supply chain.
Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @
https://www.maximizemarketresearch.com/request-sample/148295
Zonisamide Market Segmentation?
Based on Strength:
25 mg: This strength variant caters to patients requiring lower doses of Zonisamide. It may be prescribed according to individual patient needs.
50 mg: The 50 mg tablet dominates the market segment, making it a preferred choice for both patients and physicians. It is often prescribed twice a day or as a single 100 mg dose.
100 mg: Zonisamide is also available in 100 mg tablets, suitable for patients requiring higher doses. Physicians may prescribe it according to the specific needs of patients.
Based on Application:
Adult: Zonisamide is widely used in the adult population, serving as an effective treatment for epilepsy. It addresses the needs of adult patients affected by the condition.
Pediatric: While the pediatric segment shows moderate growth, Zonisamide is also prescribed for children aged between 0 to 17 years who have active epilepsy. The common dosage in pediatrics is typically 2 mg/kg, tailored to individual patient requirements.
Who are Zonisamide Market Key Players?
1. Concordia
2. Eisai
3. Zydus Pharmaceuticals
4. Sun Pharma
5. Wockhardt
6. Mylan
7. APOTEX
8. Teva
9. Glenmark
10. Bluepharma
11. Invagen Pharmaceuticals
12. Intas Pharmaceuticals
Please connect with our representative, who will ensure you to get a report sample here @
https://www.maximizemarketresearch.com/request-sample/148295
Regional Insights:
North America: The dominant market for Zonisamide, North America, accounted for 30% of the market share in 2022. With approximately 3 million epilepsy patients in the region, it boasts a well-developed healthcare infrastructure and government initiatives to improve healthcare.
Asia Pacific: Expected to grow during the forecast period, the Asia Pacific region benefits from increased government funding, improved treatment facilities, and rising disposable income. India, as a pharmaceutical hub, plays a pivotal role in this region's growth.
South America, the Middle East, and Africa: These regions are in the early stages of Zonisamide market development, driven by improved medical infrastructure and increased epilepsy prevalence.
Related Reports:
Global Torsional Vibration Dampers Market https://www.maximizemarketresearch.com/market-report/global-torsional-vibration-dampers-market/111718/
Global Hybrid Power Solutions Market https://www.maximizemarketresearch.com/market-report/global-hybrid-power-solutions-market/115583/
Synthetic Natural Gas (SNG) Market https://www.maximizemarketresearch.com/market-report/synthetic-natural-gas-sng-market/66999/
Global Industrial V-belt Market https://www.maximizemarketresearch.com/market-report/global-industrial-v-belt-market/91830/
Global Uncoated Paint Protection Film Market https://www.maximizemarketresearch.com/market-report/global-uncoated-paint-protection-film-market/25859/
Global Monolithic Microwave IC (MMIC) Market https://www.maximizemarketresearch.com/market-report/global-monolithic-microwave-ic-mmic-market/29699/
Contact Maximize Market Research:
MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 444 West Lake Street, Floor 17,
Chicago, IL, 60606, USA.
✆ +1 800 507 4489
✆ +91 9607365656
🖂 sales@maximizemarketresearch.com
🌐 www.maximizemarketresearch.com
About Maximize Market Research:
Maximize Market Research is a swiftly growing enterprise that specializes in market research and corporate advisory services, serving clients globally. With our substantial impact on revenue and unwavering commitment to research excellence, we have positioned ourselves as a trusted partner to a significant portion of Fortune 500 companies. Our comprehensive range of services caters to a diverse array of industries, including but not limited to IT, telecommunications, chemicals, food and beverages, aerospace and defense, healthcare, and beyond.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Zonisamide Market available in the latest report forecast by 2029 here
News-ID: 3191732 • Views: …
More Releases from MAXIMIZE MARKET RESEARCH PVT. LTD.
B2B Payments Market Expands from USD 1603.32 Bn in 2023 to USD 3010.91 Bn by 203 …
B2B Payments Market size was valued at USD 1603.32 Billion in 2023 and the total B2B Payments revenue is expected to grow at a CAGR of 9.42% from 2024 to 2030, reaching nearly USD 3010.91 Billion by 2030.
B2B Payments Market Overview:
The B2B payments market has become an essential part of global trade and commerce, providing businesses with secure and efficient ways to transfer funds across industries and borders. Traditionally dominated…
Financial Guarantee Market Expands from USD 39.92 Bn in 2023 to USD 74.87 Bn by …
Financial Guarantee Market size was valued at USD 39.92 billion in 2023 and the total Financial Guarantee Market revenue is expected to grow at a CAGR of 9.4 % from 2024 to 2030, reaching nearly USD 74.87 billion.
Financial Guarantee Market Overview:
The financial guarantee market plays a crucial role in global trade and investment by providing assurance to lenders, investors, and stakeholders about the repayment or fulfillment of financial obligations. These…
Knowledge Graph Market to Reach USD 3.42 Bn by 2030, Growing at 18.1% CAGR
Knowledge Graph Market size was valued at USD 1.06 Billion in 2023 and the total Knowledge Graph revenue is expected to grow at a CAGR of 18.1 % from 2024 to 2030, reaching nearly USD 3.42 Billion.
Knowledge Graph Market Overview:
The knowledge graph market has grown significantly as organizations increasingly rely on advanced data management tools to harness structured and unstructured information. Knowledge graphs enable businesses to establish connections between disparate…
No-Code AI Platform Market to Reach USD 29.54 Bn by 2030, Growing at 28.6% CAGR
No-Code AI Platform Market size was valued at USD 5.07 Bn. in 2023 and the total No-Code AI Platform revenue is expected to grow by 28.6 % from 2024 to 2030, reaching nearly USD 29.54 Bn.
No-Code AI Platform Market Overview:
The no-code AI platform market has gained significant traction as organizations increasingly seek simplified solutions for building and deploying artificial intelligence applications. These platforms allow users with little or no programming…
More Releases for Zonisamide
Smoking Cessation Treatment Market Size was ~USD 1800 Million in 2022, estimated …
Smoking Cessation Therapies such as Bupropion, Zonisamide, Cytisinicline, Nicoderm, Varenicline, and others"
The Smoking Cessation Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition. The pipeline for Smoking Cessation therapeutics includes promising candidates that aim to not only treat acute attacks but also prevent recurrence.
DelveInsight's "Smoking Cessation Market Insight, Epidemiology, and Market Forecast - 2034" report…
Smoking Cessation Treatment Market Size was ~USD 1800 Million in 2022, estimated …
"Smoking Cessation Therapies such as Bupropion, Zonisamide, Cytisinicline, Nicoderm, Varenicline, and others"
The Smoking Cessation Market is projected to witness substantial growth over the next few years, driven by advancements in treatment modalities and increasing awareness of the condition. The pipeline for Smoking Cessation therapeutics includes promising candidates that aim to not only treat acute attacks but also prevent recurrence.
DelveInsight's "Smoking Cessation Market Insight, Epidemiology, and Market Forecast - 2034" report…
Zonisamide Market Poised for Steady Growth with 3.9% CAGR Forecast
Zonisamide Market, Surge in Epilepsy Cases Fuels Growth
Unveiling the Dynamics of the Zonisamide Market: An In-Depth Exploration by Maximize Market Research:
Amidst the backdrop of a global surge in epilepsy cases, the Zonisamide market witnesses a significant uptick, projecting a promising future. According to recent reports, the Zonisamide Market, valued at US$ 353.26 million in 2022, is expected to grow at a CAGR of 3.9% through the forecast period.
Epilepsy, a chronic…
API Testing Market Worldwide Industry Analysis, Future Demand and Forecast till …
31.8.2023:nAPI Testing Market Set to Surge, Projected to Reach US$ 937.37 Mn by 2022
Report Scope and Methodology:
Report Overview and Scope
The comprehensive report delves into the API Testing Market, unveiling market values, growth potential, and regional insights. It encompasses crucial segments such as deployment type, component, and vertical, offering a panoramic understanding of market dynamics. The report offers insights into market drivers, restraints, challenges, opportunities, and future prospects.
Research Methodology
The report employs…
Zonisamide Market Forecast 2020-2026: Mylan, Concordia, Sun Pharma, Glenmark, Bl …
The newly issued research report provides comprehensive and an in-depth assessment of the "Global Zonisamide Market Forecast 2020-2026", which will also offer relevant data for the new industry entrants as well as well-established Zonisamide market players. According to the study, the worldwide Zonisamide market report unfolds the current and historical Zonisamide industry scenarios, Zonisamide market development patterns and is expected to proceed with continuous manufacturing over the predicted period.
The research…
Latest Report on Zonisamide Market Outlook 2019 Size, Share, Global Industry App …
Zonisamide is used with other medications to prevent and control seizures (epilepsy). Zonisamide is a sulfonamide anticonvulsant and a carbonic anhydrase inhibitor.
The Global Zonisamide Market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026.
Increase in prevalence of mental illness and epilepsy are stimulating the market growth. However, alternative…
